Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Successful management of Candida krusei monoarthritis after allo-SCT.

Mayer K, Kapelle M, Kaeferstein A, Weßling M, Bekeredjian-Ding I, Leutner C, von Lilienfeld-Toal M, Brossart P, Wolf D.

Bone Marrow Transplant. 2013 Nov;48(12):1585-6. doi: 10.1038/bmt.2013.108. Epub 2013 Jul 29. No abstract available.

PMID:
23892331
2.

Candida krusei arthritis in an adolescent with acute myelogenous leukemia.

Larru B, Barrett DM, Gerber JS.

Pediatr Infect Dis J. 2013 Oct;32(10):1142-4. doi: 10.1097/INF.0b013e318294b012.

PMID:
23563520
3.

Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT.

Blennow O, Remberger M, Klingspor L, Omazic B, Fransson K, Ljungman P, Mattsson J, Ringdén O.

Bone Marrow Transplant. 2010 Dec;45(12):1710-8. doi: 10.1038/bmt.2010.38. Epub 2010 Mar 1.

PMID:
20190840
4.

Outpatient reduced-intensity allogeneic stem cell transplantation for patients with refractory or relapsed lymphomas compared with autologous stem cell transplantation using a simplified method.

Gutiérrez-Aguirre CH, Ruiz-Argüelles G, Cantú-Rodríguez OG, González-Llano O, Jaime-Pérez JC, García-Rodríguez F, López-Otero A, Herrera-Garza JL, Gómez-Almaguer D.

Ann Hematol. 2010 Oct;89(10):1045-52. doi: 10.1007/s00277-010-0986-1. Epub 2010 May 21.

PMID:
20490794
5.
6.

Candida krusei sepsis secondary to oral colonization in a hemopoietic stem cell transplant recipient.

Westbrook SD, Kirkpatrick WR, Freytes CO, Toro JJ, Bernardo S, Patterson TF, Redding SW, Lee SA.

Med Mycol. 2007 Mar;45(2):187-90.

PMID:
17365656
7.

Candidaemia in allogeneic stem cell transplant recipients: low risk without fluconazole prophylaxis.

Jantunen E, Nihtinen A, Volin L, Juvonen E, Parkkali T, Ruutu T, Anttila VJ.

Bone Marrow Transplant. 2004 Nov;34(10):891-5.

PMID:
15517009
8.

Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients.

Plantinga TS, van der Velden WJ, Ferwerda B, van Spriel AB, Adema G, Feuth T, Donnelly JP, Brown GD, Kullberg BJ, Blijlevens NM, Netea MG.

Clin Infect Dis. 2009 Sep 1;49(5):724-32. doi: 10.1086/604714.

PMID:
19614557
9.

Oral candidiasis in hematopoietic cell transplantation patients: an outcome-based analysis.

Epstein JB, Hancock PJ, Nantel S.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 Aug;96(2):154-63.

PMID:
12931087
10.

Candida krusei fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital.

Muñoz P, Sánchez-Somolinos M, Alcalá L, Rodríguez-Créixems M, Peláez T, Bouza E.

J Antimicrob Chemother. 2005 Feb;55(2):188-93. Epub 2005 Jan 13.

PMID:
15650001
11.

Candida parapsilopsis fungemias in bone marrow transplant recipients: implications for azole prophylactic therapy.

López-Jiménez J, Duarte-Palomino R, Cabezudo E, Velasco-Martínez JJ, Sousa A, Odriozola J.

Blood. 1997 May 1;89(9):3491-2. No abstract available.

12.

Tandem autologous/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: long-term follow-up.

Björkstrand B, Iacobelli S, Hegenbart U, Gruber A, Greinix H, Volin L, Narni F, Musto P, Beksac M, Bosi A, Milone G, Corradini P, Goldschmidt H, de Witte T, Morris C, Niederwieser D, Gahrton G.

J Clin Oncol. 2011 Aug 1;29(22):3016-22. doi: 10.1200/JCO.2010.32.7312. Epub 2011 Jul 5. Erratum in: J Clin Oncol. 2011 Sep 20;29(27):3721.

PMID:
21730266
13.

Candida prosthetic infections: case series and literature review.

Dutronc H, Dauchy FA, Cazanave C, Rougie C, Lafarie-Castet S, Couprie B, Fabre T, Dupon M.

Scand J Infect Dis. 2010 Dec;42(11-12):890-5. doi: 10.3109/00365548.2010.498023. Epub 2010 Jul 7. Review.

PMID:
20608769
14.

Esophageal perforation secondary to angio-invasive Candida glabrata following hemopoietic stem cell transplantation.

Tran HA, Vincent JM, Slavin MA, Grigg A.

Clin Microbiol Infect. 2003 Dec;9(12):1215-8.

15.

Multifocal osteomyelitis caused by Candida dubliniensis.

Wellinghausen N, Moericke A, Bundschuh S, Friedrich W, Schulz AS, Gatz SA.

J Med Microbiol. 2009 Mar;58(Pt 3):386-90. doi: 10.1099/jmm.0.003970-0.

PMID:
19208893
16.

Clinical Candida krusei isolates remain susceptible during extensive exposure to antifungal drugs.

Hautala T, Kakko S, Siitonen T, Säily M, Koistinen P, Koskela M.

Med Mycol. 2010 Feb;48(1):79-84. doi: 10.3109/13693780902725276.

PMID:
19194820
17.

Long-term outcome after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with multiple myeloma.

El-Cheikh J, Crocchiolo R, Furst S, Stoppa AM, Ladaique P, Faucher C, Calmels B, Lemarie C, De Colella JM, Granata A, Coso D, Bouabdallah R, Chabannon C, Blaise D.

Am J Hematol. 2013 May;88(5):370-4. doi: 10.1002/ajh.23412. Epub 2013 Mar 5.

18.

Incidence of Viral and fungal infections following busulfan-based reduced-intensity versus myeloablative conditioning in pediatric allogeneic stem cell transplantation recipients.

Satwani P, Baldinger L, Freedman J, Jacobson JS, Guerra J, van de Ven C, Morris E, Garvin J, George D, Bradley MB, Bhatia M, Tallamy B, Schwartz J, Jin Z, Cairo MS.

Biol Blood Marrow Transplant. 2009 Dec;15(12):1587-95. doi: 10.1016/j.bbmt.2009.08.006. Epub 2009 Sep 30.

19.

[Frequency of oral candidiasis in stem cell transplant patients].

Hermann P, Berek Z, Kriván G, Márton K, Fejérdy P, Lengyel A.

Fogorv Sz. 2006 Feb;99(1):9-14. Hungarian.

PMID:
16607934
20.

Lower respiratory tract respiratory virus infections increase the risk of invasive aspergillosis after a reduced-intensity allogeneic hematopoietic SCT.

Martino R, Piñana JL, Parody R, Valcarcel D, Sureda A, Brunet S, Briones J, Delgado J, Sánchez F, Rabella N, Sierra J.

Bone Marrow Transplant. 2009 Dec;44(11):749-56. doi: 10.1038/bmt.2009.78. Epub 2009 Apr 27.

PMID:
19398963

Supplemental Content

Support Center